Our results are in line with recently published data including a cohort of 30 patients with hormone-resistant PCa classified as non-metastatic by conventional imaging, in which 68Ga-PSMA-11 PET/CT revealed PSMA-positive disease in 90% of all patients [8]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.